Trends and Variations in Emergency Department Use Associated With Diabetes in the US by Sociodemographic Factors, 2008-2017.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
02 05 2022
Historique:
entrez: 25 5 2022
pubmed: 26 5 2022
medline: 28 5 2022
Statut: epublish

Résumé

Little is known about emergency department (ED) use among people with diabetes and whether the pattern of ED use varies across geographic areas and population subgroups. To estimate recent national- and state-level trends in diabetes-related ED use overall and by race and ethnicity, rural or urban location, and insurance status. This cross-sectional study of adults visiting the ED with a diabetes-related diagnosis used serial data from the Nationwide Emergency Department Sample, a nationally representative database, and discharge records from 11 state emergency department databases for 2008, 2011, 2014, and 2016 to 2017. Data were analyzed from March 16 to November 9, 2020. Reported race and ethnicity, rural or urban location, and insurance status. Data were stratified to generate state-specific estimates. Rates of ED use for all-cause visits among adults with diabetes (all-cause diabetes visits) and visits with primary diagnoses of diabetes-specific complications. A larger portion of all-cause diabetes ED visits (n = 32 433 015) were by female (56.8%) and middle-aged (mean [SD] age, 58.4 [16.3] years) adults with diabetes. Nationally, all-cause diabetes ED visits per 10 000 adults increased 55.6% (95% CI, 50.6%-60.6%), from 257.6 (95% CI, 249.9-265.3) visits in 2008 to 400.8 (95% CI, 387.6-414.0) visits in 2017. All-cause diabetes ED visits increased more for urban (58.3%; 95% CI, 52.5%-64.1%) and uninsured subgroups (75.3% [95% CI, 59.8%-90.8%]) than for their counterparts. Diabetes-specific ED visits (weighted number of 1 911 795) nationally increased slightly among all subgroups. State-specific ED use rates show wide state-to-state variations in ED use by race and ethnicity, rural or urban location, and insurance. On average across states, diabetes-specific ED use among Black patients was approximately 3 times (rate ratio, 3.09 [95% CI, 2.91-3.30]) greater than among non-Hispanic White patients, and among Hispanic patients, it was 29% greater (rate ratio, 1.29 [95% CI, 1.19-1.40]) than among non-Hispanic White patients. The mean rate of ED use among rural patients was 34% greater (rate ratio, 1.34 [95% CI, 1.26-1.44]) than among urban patients. The mean rates of ED use among patients with Medicaid (rate ratio, 6.65 [95% CI, 6.49-6.82]) and Medicare (rate ratio, 4.37 [95% CI, 4.23-4.51]) were greater than among privately insured adults. This study suggests that disparities in diabetes-related ED use associated with race and ethnicity, rural or urban location, and insurance status were persistent from 2008 to 2017 within and across states, as well as nationally. Further geographic and demographic-specific analyses are needed to understand the sources of inequity.

Identifiants

pubmed: 35612855
pii: 2792674
doi: 10.1001/jamanetworkopen.2022.13867
pmc: PMC9133946
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2213867

Références

J Diabetes Complications. 2009 Mar-Apr;23(2):112-8
pubmed: 18413179
Ann Emerg Med. 2018 Nov;72(5):523-532
pubmed: 30342727
Diabetes Care. 2015 Feb;38(2):186-8
pubmed: 25614688
BMJ Open Diabetes Res Care. 2021 Oct;9(1):
pubmed: 34686496
Diabetes Care. 2022 Jun 2;45(6):1355-1363
pubmed: 35380629
Arch Intern Med. 2011 Aug 8;171(15):1397-9
pubmed: 21824959
Diabetes Care. 2020 May;43(5):1057-1064
pubmed: 32161050
J Diabetes Complications. 2018 May;32(5):458-464
pubmed: 29526624
Med Care. 2003 Nov;41(11):1221-32
pubmed: 14583685
N Engl J Med. 2013 Apr 25;368(17):1613-24
pubmed: 23614587
J Am Med Dir Assoc. 2016 Jun 1;17(6):541-6
pubmed: 27052563
Clin Diabetes. 2017 Oct;35(4):232-238
pubmed: 29109613
Diabetes Care. 2018 May;41(5):917-928
pubmed: 29567642
PLoS One. 2015 Aug 07;10(8):e0134917
pubmed: 26252486
J Health Care Poor Underserved. 2014 May;25(2):801-13
pubmed: 24858887
J Urban Health. 2014 Oct;91(5):873-85
pubmed: 24532483
Ann Transl Med. 2016 Jan;4(2):30
pubmed: 26889483
J Diabetes. 2021 Jan;13(1):78-88
pubmed: 32851797
Am J Manag Care. 2018 May;24(5):225-231
pubmed: 29851439
Ethn Health. 2019 Apr;24(3):245-256
pubmed: 28393538
MMWR Morb Mortal Wkly Rep. 2016 Nov 18;65(45):1265-1269
pubmed: 27855140
Med Care. 2019 Dec;57(12):949-959
pubmed: 31568164
PLoS One. 2017 Dec 27;12(12):e0189676
pubmed: 29281696
Prev Chronic Dis. 2015 Nov 19;12:E200
pubmed: 26583572
NCHS Data Brief. 2018 Feb;(301):1-8
pubmed: 29442992
JAMA Netw Open. 2020 May 1;3(5):e203857
pubmed: 32356883
Ann Emerg Med. 2017 Aug;70(2):215-225.e6
pubmed: 28641909
BMC Health Serv Res. 2017 Apr 14;17(1):273
pubmed: 28410614
Ann Emerg Med. 2010 Aug;56(2):150-65
pubmed: 20074834
N Engl J Med. 2014 Apr 17;370(16):1514-23
pubmed: 24738668
Soc Sci Med. 2016 Aug;162:88-96
pubmed: 27343818
J Rural Health. 2018 Mar;34(2):213-222
pubmed: 29105809
Health Equity. 2019 May 15;3(1):211-218
pubmed: 31289781
Stroke. 2008 Jun;39(6):1675-80
pubmed: 18388336
Diabetes Care. 2018 May;41(5):929-932
pubmed: 29678864
Health Serv Res. 2015 Aug;50 Suppl 1:1273-99
pubmed: 26150118
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131
Diabetes Care. 2010 Jul;33(7):1463-70
pubmed: 20357367
Ann Intern Med. 2014 Nov 18;161(10):681-9
pubmed: 25402511
Diabetes Care. 2012 Jul;35(7):1566-71
pubmed: 22522664
Diabetes Care. 2003 Aug;26(8):2392-9
pubmed: 12882868

Auteurs

Tegveer S Uppal (TS)

Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia.

Puneet Kaur Chehal (PK)

Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, Georgia.

Gail Fernandes (G)

Merck & Co Inc, Kenilworth, New Jersey.

J Sonya Haw (JS)

Division of Endocrinology and Metabolism, Department of Medicine, School of Medicine, Emory University, Atlanta, Georgia.

Megha Shah (M)

Department of Family and Preventive Medicine, School of Medicine, Emory University, Atlanta, Georgia.

Sara Turbow (S)

Department of Family and Preventive Medicine, School of Medicine, Emory University, Atlanta, Georgia.
Division of General Medicine and Geriatrics, Department of Medicine, School of Medicine, Emory University, Atlanta, Georgia.

Swapnil Rajpathak (S)

Merck & Co Inc, Kenilworth, New Jersey.

K M Venkat Narayan (KMV)

Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia.

Mohammed K Ali (MK)

Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia.
Department of Family and Preventive Medicine, School of Medicine, Emory University, Atlanta, Georgia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH